Covalon Technologies (OTCMKTS:CVALF – Get Free Report) released its earnings results on Thursday. The company reported $0.07 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.06, Zacks reports. Covalon Technologies had a net margin of 5.05% and a return on equity of 5.77%. The company had revenue of $7.07 million for the quarter, compared to analysts’ expectations of $6.65 million.
Covalon Technologies Trading Up 28.1%
CVALF opened at $2.12 on Friday. The firm has a market cap of $58.55 million, a P/E ratio of 53.01 and a beta of 0.59. The stock has a 50-day moving average of $1.58 and a 200 day moving average of $1.45. Covalon Technologies has a 12 month low of $1.16 and a 12 month high of $2.15.
Covalon Technologies Company Profile
Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.
The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.
See Also
- Five stocks we like better than Covalon Technologies
- CrowdStrike’s “Mythos Moment” Tests the Bigger AI Security Trade
- 3 Stocks Facing New Pressure From Section 338 Tariffs on Canadian Goods
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
